REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
Go back to REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting| Jennison Natural Resources Fund Class B (NASDAQ: RGNX) | Delayed: 7.22 -0.18 (2.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.40 | 52 Week High | $25.00 | |||
| Open | $7.30 | 52 Week Low | $7.07 | |||
| Day High | $7.32 | P/E | N/A | |||
| Day Low | $7.17 | EPS | $0.00 | |||
| Volume | 278,424 | |||||
